TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biovac Sverige AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
37,723
|
44,634
|
40,187 |
| Financial expenses |
58
|
131
|
67 |
| Earnings before taxes |
533
|
1,537
|
-1,414 |
| EBITDA |
697
|
1,798
|
-1,227 |
| Total assets |
13,212
|
12,076
|
11,023 |
| Current assets |
11,338
|
9,954
|
8,899 |
| Current liabilities |
8,102
|
7,468
|
8,141 |
| Equity capital |
5,110
|
4,608
|
2,882 |
| - share capital |
77
|
76
|
71 |
| Employees (average) |
8
|
9
|
9 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
38.7%
|
38.2%
|
26.1% |
| Turnover per employee |
4,715
|
4,959
|
4,465 |
| Profit as a percentage of turnover |
1.4%
|
3.4%
|
-3.5% |
| Return on assets (ROA) |
4.5%
|
13.8%
|
-12.2% |
| Current ratio |
139.9%
|
133.3%
|
109.3% |
| Return on equity (ROE) |
10.4%
|
33.4%
|
-49.1% |
| Change turnover |
-7,716
|
1,596
|
-192 |
| Change turnover % |
-17%
|
4%
|
0% |
| Chg. No. of employees |
-1
|
0
|
1 |
| Chg. No. of employees % |
-11%
|
0%
|
13% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.